Acquisitions - Additional Information (Details) - USD ($) |
12 Months Ended | |
|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Cultured Foods | ||
| Business Acquisition [Line Items] | ||
| Acquisition costs | $ 100,000 | |
| Useful life to acquired intangible assets | 5 years | |
| Fair value of earn-out provision | $ 88,000 | |
| Cultured Foods | Selling, General and Administrative Expenses | ||
| Business Acquisition [Line Items] | ||
| Change in fair value of earn-out | 88,000 | |
| Elevated Softgels | ||
| Business Acquisition [Line Items] | ||
| Acquisition costs | $ 13,704,000 | |
| Useful life to acquired intangible assets | 5 years | |
| Fair value of earn-out provision | $ 100,000 |
| X | ||||||||||
- Definition Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of addition (reduction) to the amount at which a liability could be incurred (settled) in a current transaction between willing parties. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|